Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study

Clinical trial NCT00553358 · COMPLETED

Trial details

NCT number: NCT00553358
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2008-01-05
Primary completion: 2010-05-27
Enrollment: 455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.